Unpublished pharma data states it has Hep C treatment cure rate of 99 percent

Madely Health Headlines Commentary for October 16, 2012


Abbott Labs rises on hepatitis C drug data


This press release does not cite published studies. Nor do we know if there were negative outcomes in other clinical trials. There is no obligation on the part of pharma to release details of stiudies that cast a negative outcome for their product.